Allergan Rejects $46B Bid by Valeant Pharmaceuticals

Now watching

Next video starts in : 7 Play

Allergan Rejects $46B Bid by Valeant Pharmaceuticals

Allergan Rejects $46B Bid by Valeant Pharmaceuticals
Replay video
Up next

Hackers Dupe Businesses Into Wiring Them Large Sums

Unlock your personal NFL Now stream by signing in to NFL.com

Allergan Rejects $46B Bid by Valeant Pharmaceuticals

by WSJ Live 2:54 mins

Victor Reklaitis takes a look at the markets, including three stocks to watch today. Photo: Getty.

View Comments (0)